FASLODEX is a hormonal treatment for hormone receptor-positive metastatic breast cancer in postmenopausal women whose breast cancer recurred or progressed following antiestrogen therapy. Therefore, it is only approved for distant breast cancer recurrence.
Breast cancer recurrence
Local recurrence occurs in the breast where the cancer first started, or in the skin and underlying tissues where the breast used to be. This type of breast cancer recurrence can happen even if you’ve had a mastectomy.
Regional recurrence occurs in the lymph nodes near the affected breast. These regional lymph nodes include nodes found under the arm (axillary nodes), in the neck, and in the chest wall.
Distant recurrence occurs in other parts of the body, such as the bones, liver, lungs, or brain. This is also called metastatic breast cancer.